CREPT is required for the metastasis of triple-negative breast cancer through a co-operational-chromatin loop-based gene regulation.

Researchers reported that CREPT/RPRD1B, which exhibits somatic gene copy-number amplifications and elevated expression, correlated with poor patient survival and drives TNBC metastasis.